Brian McNamee
Chairman bei CSL LIMITED
Vermögen: 24 Mio $ am 31.03.2024
Profil
Dr. Brian A. McNamee, MD, ist ein Principal bei Tarnagulla Ventures Pty Ltd. Er ist Mitglied des Board of Directors bei Zenyth Therapeutics Ltd. Dr. McNamee war zuvor als unabhängiger Direktor bei Gen-Probe, Inc. beschäftigt, als Chief Executive Officer, Executive Director & MD bei CSL Ltd, als Präsident bei ZLB Behring LLC, als General Manager-Faulding Product Divisions bei FH Faulding & Co. Ltd. und Managing Director bei Pacific Biotechnology Ltd. Außerdem war er Vorstandsmitglied bei Gen-Probe, Inc. und Peter Maccallum Cancer Foundation Ltd. Er erhielt seinen Bachelor-Abschluss von der University of Melbourne und einen Doktortitel von der University of Melbourne.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CSL LIMITED
0,03% | 16.02.2024 | 126 227 ( 0,03% ) | 24 Mio $ | 31.03.2024 |
Aktive Positionen von Brian McNamee
Unternehmen | Position | Beginn |
---|---|---|
ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
CSL LIMITED | Chairman | 17.10.2018 |
Geoff Ogilvy Foundation | Chairman | 01.05.2021 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chairman | - |
Ehemalige bekannte Positionen von Brian McNamee
Unternehmen | Position | Ende |
---|---|---|
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Chairman | 01.06.2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | President | 01.07.2013 |
CSL LIMITED | President | 01.07.2013 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Director/Board Member | 31.05.2007 |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - |
Ausbildung von Brian McNamee
University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CSL LIMITED | Health Technology |
Private Unternehmen | 9 |
---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
FH Faulding & Co. Ltd. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
Geoff Ogilvy Foundation |